Today, the announcement of positive clinical trial results has sent investors in Edesa Biotech and EDSA stock on a nice ride. More
Articles
BRLT Stock IPO: When Does Brilliant Earth Go Public? What Is the Brilliant Earth IPO Price Range?
This trading week may be off to a rough start, but investors looking for some sparkle should turn to the Brilliant Earth IPO and BRLT stock. More
AT&T’s Dividend Yield Prediction Implies It Has Further to Fall
AT&T's CFO sheds light on the effect of the Warner Bros Discovery deal on the dividend. T stock could fall to $22.10 based on today's yield. More
Moderna Has Ripped Through Analyst Estimates This Year, and Might Not Stop
Moderna has blasted through analysts' earnings this year and might keep doing that. FCF could end up much more than analysts foresee next year, pushing MRNA stock 44% higher to $618 per share. More
Short Squeeze Stocks: BBIG, ATER and 3 Others Experts Think Are Ready to Pop
Investors looking to find the top short squeeze stocks to buy right now may want to take a look at this curated list of opportunities. More
Weekly Upgrades and Downgrades
During these busy times, it pays to stay on top of the latest profit opportunities. And today's blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company's fundamental health, I decided to revise my Portfolio Grader recommendations for 129 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. More
